-
1
المؤلفون: Debra L. Miller, Stephen J. Nicholls, Steven E. Nissen, Kausik K. Ray, Giacomo Ruotolo, Lauren A. Beacham, Jeffrey S. Riesmeyer, Christie M. Ballantyne
مصطلحات موضوعية: Male, Time Factors, Cardiac & Cardiovascular Systems, Atorvastatin, 030204 cardiovascular system & hematology, Pharmacology, chemistry.chemical_compound, Benzodiazepines, 0302 clinical medicine, Clinical trials, Medicine, 030212 general & internal medicine, biology, Anticholesteremic Agents, WOMEN, MEN, Middle Aged, Cardiovascular disease, Lipids, Treatment Outcome, Tolerability, SAFETY, Drug Therapy, Combination, Female, lipids (amino acids, peptides, and proteins), Inflammation Mediators, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, medicine.drug, ACCENTUATE Investigators, Statin, medicine.drug_class, HEART-DISEASE, Placebo, 1102 Cardiovascular Medicine And Haematology, EVENTS, 03 medical and health sciences, Ezetimibe, Double-Blind Method, Cholesterylester transfer protein, CETP, Humans, cardiovascular diseases, Aged, Dyslipidemias, Science & Technology, business.industry, ACUTE CORONARY SYNDROMES, nutritional and metabolic diseases, 1103 Clinical Sciences, Atherosclerosis, PREVENTION, United States, Cholesterol Ester Transfer Proteins, HIGH-RISK, chemistry, Peripheral Vascular Disease, EVACETRAPIB, Cardiovascular System & Hematology, PRAVASTATIN, biology.protein, Cardiovascular System & Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Pravastatin, Evacetrapib, Biomarkers
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8fdd7b9b360b1eb1a86465c33918f3
http://hdl.handle.net/10044/1/50859